Clinical evidence for an LH ‘ceiling’ effect induced by administration of recombinant human LH during the late follicular phase of stimulated cycles in World Health Organization type I and type II anovulation

Author： Loumaye Ernest  

Publisher： Oxford University Press

ISSN： 1460-2350

Source： Human Reproduction, Vol.18, Iss.2, 2003-02, pp. : 314-322

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Reproductive endocrinology. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain

By Burgués S.  

Human Reproduction, Vol. 16, Iss. 12, 2001-12 ,pp. : 2525-2532

Oxford University Press

Access to resources Recommend Favorite

What is the LH ceiling level for follicular growth arrest in late follicular phase?

By Ho Jason Yen‐Ping  

Human Reproduction, Vol. 19, Iss. 2, 2004-02 ,pp. : 463-464

Oxford University Press

Access to resources Recommend Favorite

Clinical evidence for an LH ceiling?

By Loumaye Ernest  

Human Reproduction, Vol. 18, Iss. 12, 2003-12 ,pp. : 2719-2720

Oxford University Press

Access to resources Recommend Favorite

What clinical evidence for an LH ceiling?

By Filicori Marco   Cognigni Graciela E.   Ciampaglia Walter  

Human Reproduction, Vol. 18, Iss. 7, 2003-07 ,pp. : 1556-1557

Oxford University Press

Access to resources Recommend Favorite

Recombinant human LH supplementation during GnRH antagonist administration in IVF/ICSI cycles: a prospective randomized study

By Cédrin-Durnerin I.  

Human Reproduction, Vol. 19, Iss. 9, 2004-09 ,pp. : 1979-1984

Oxford University Press

Access to resources Recommend Favorite